Decheng Capital — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Mirviemirvie.cominJul 2025
Mirvie develops an RNA-based platform for early detection of pregnancy complications, enabling proactive intervention before complications become critical.
BiotechFemTechHealthtechSouth San Francisco, US
Maneesh Jain(Executive Officer, Director, Promoter)inStephen Quake(Director)
BoardLisa Iverson(Director)Ursheet Parikh(Director)inMin Cui(Director)inSamir Kaul(Director)in
Co-investorsMayfield FundPortfoliaForesite CapitalGeneral CatalystKhosla Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.